All Pharma News
Leap Therapeutics Announces $40 Million Private Placement

Leap Therapeutics Announces $40 Million Private Placement
PR NEWSWIRE
11 Apr 2024
Share Share
Leap Therapeutics Announces Initiation of Part B of the DeFianCe Study of DKN-01

Leap Therapeutics Announces Initiation of Part B of the DeFianCe Study of DKN-01
PR NEWSWIRE
12 Jul 2023
Share Share
Leap Announces Completion of Enrollment in Part A of DeFianCe Study of DKN-01

Leap Announces Completion of Enrollment in Part A of DeFianCe Study of DKN-01
PR NEWSWIRE
12 Apr 2023
Share Share
BeiGene lets option on Leap’s immuno-oncology candidate lapse

BeiGene lets option on Leap’s immuno-oncology candidate lapse
Nick Paul Taylor FIERCE BIOTECH
18 Mar 2023
Share Share
Leap picks up anti-Claudin assets via Flame merger

Leap picks up anti-Claudin assets via Flame merger
BIOPHARMADIVE
18 Jan 2023
Share Share
Leap Therapeutics Announces First Patient Enrolled in DeFianCe Study of DKN-01

Leap Therapeutics Announces First Patient Enrolled in DeFianCe Study of DKN-01
PRNEWSWIRE
17 Oct 2022
Share Share
Leap Tx to Present Data from Investigator-Sponsored Study of DKN-01 + Docetaxel

Leap Tx to Present Data from Investigator-Sponsored Study of DKN-01 + Docetaxel
PRNEWSWIRE
26 May 2022
Share Share
Leap Tx to Present at Raymond James 43rd Annual Institute Investors Conference

Leap Tx to Present at Raymond James 43rd Annual Institute Investors Conference
PRNEWSWIRE
02 Mar 2022
Share Share
Leap Therapeutics Announces Closing of Public Offering of Common Stock

Leap Therapeutics Announces Closing of Public Offering of Common Stock
PRNEWSWIRE
24 Sep 2021
Share Share
Leap Therapeutics plunges on stock and pre-funded warrants offering

Leap Therapeutics plunges on stock and pre-funded warrants offering
SEEKINGALPHA
21 Sep 2021
Share Share